Previous Close | 13.13 |
Open | 13.00 |
Bid | 12.73 x 200 |
Ask | 12.79 x 200 |
Day's Range | 12.51 - 13.05 |
52 Week Range | 7.07 - 15.43 |
Volume | |
Avg. Volume | 631,480 |
Market Cap | 823.327M |
Beta (5Y Monthly) | 1.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.04 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.29 |
NEWPORT BEACH, Calif., May 10, 2024--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759 restricted stock units (RSUs) of the company’s common stock to 14 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company’s board of dir
NEWPORT BEACH, Calif., May 10, 2024--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that its Chief Financial Officer, Sandra Beaver, has been awarded Outstanding CFO of a Public Company by the Orange County Business Journal. The award is given to CFOs for outstanding performance as corporate stewards.
Evolus ( NASDAQ:EOLS ) First Quarter 2024 Results Key Financial Results Revenue: US$59.3m (up 42% from 1Q 2023). Net...